|
2024
|
Invention
|
Anti-cd3 multispecific antibody and use thereof. Provided are multispecific antibodies targeting ... |
|
|
Invention
|
Anti-cd3 and anti-cd3 multispecific antibodies, and use. Provided are an antibody specifically bi... |
|
|
Invention
|
Anti-pd-1-anti-vegf bispecific antibody, pharmaceutical composition thereof and use thereof. The ... |
|
|
Invention
|
Compositions and methods for treating solid tumors with anti-btla as combination therapy. Relates... |
|
2023
|
Invention
|
Stable heavy isotopes in amide functional groups and uses thereof.
There are provided isotope-en... |
|
|
Invention
|
Anti-lair1 antibodies and their uses. Provided are anti-LAIR1 antibodies and uses thereof in the ... |
|
|
Invention
|
Linker for antibody-drug conjugate and use thereof. The present invention relates to a linker for... |
|
|
Invention
|
Anti-cd93 antibody, and composition and use thereof. The present invention provides an anti-CD93 ... |
|
|
Invention
|
Anti-cgrp antibody and use. Provided are an antibody specifically binding to CGRP or an antigen-b... |
|
|
Invention
|
Bispecific antibody targeting cd112r and tigit and use thereof.
The present disclosure provides ... |
|
|
Invention
|
Anti-cd112r antibody pharmaceutical composition and use thereof. Provided are a stable anti-CD112... |
|
|
Invention
|
Biomarkers and methods for treating nsclc. Biomarkers and methods for the treatment of non-small ... |
|
|
Invention
|
A method of treating solid tumor. Use of a CD73 antibody or an antigen binding fragment thereof i... |
|
|
Invention
|
Combination of anti-pd-1 antibody and anti-egfr antibody, and use thereof in treatment of head an... |
|
|
Invention
|
Compositions and methods for treating solid tumors with anti-btla as mono or combination therapy.... |
|
|
Invention
|
Use of combination of anti-pd-1 antibody and anti-vegf antibody in treatment of hepatocellular ca... |
|
|
Invention
|
Anti-dkk1 antibody, pharmaceutical composition thereof, and use thereof.
The present invention b... |
|
|
Invention
|
Anti-dkk1 antibody, pharmaceutical composition thereof and use thereof. The present invention bel... |
|
|
Invention
|
Anti-cd3 and anti-cd20 bispecific antibody and use thereof.
The present invention provides a bis... |
|
|
Invention
|
Anti-cd3 and anti-cd20 bispecific antibody and use thereof. The present invention provides a bisp... |
|
|
Invention
|
Pharmaceutical composition of anti-ctla-4 antibody and use thereof. Provided in the present inven... |
|
2022
|
Invention
|
Anti-bcma antibody and use thereof. Provided are an antibody capable of specifically binding to B... |
|
|
Invention
|
Anti-4-1bb antibody and use thereof. Provided are an antibody capable of specifically binding to ... |
|
|
Invention
|
Antibody binding to cd3, and use thereof. Provided are an antibody binding to CD3 and a use there... |
|
|
Invention
|
Anti-cldn-18.2 antibody-drug conjugate and use thereof.
Provided are an anti-CLDN-18.2 antibody-... |
|
|
Invention
|
Anti-cldn-18.2 antibody-drug conjugate and use thereof. Provided are an anti-CLDN-18.2 antibody-d... |
|
|
Invention
|
Anti-pd-1 antibody pharmaceutical composition and use thereof.
The present disclosure provides a... |
|
|
Invention
|
Anti-pd-1 antibody pharmaceutical composition and use thereof. A stable anti-PD-1 antibody pharma... |
|
|
Invention
|
Anti-btla antibody pharmaceutical composition and use thereof.
The present invention provides a ... |
|
|
Invention
|
Sirna inhibiting angptl3 gene expression, and use thereof. The present invention relates to siRNA... |
|
|
Invention
|
Use of anti-pd-1 antibody in combination with chemotherapy in treating esophageal cancer.
The pr... |
|
|
Invention
|
Use of anti-pd-1 antibody in combination with chemotherapy in treating esophageal cancer. Related... |
|
|
Invention
|
Drug and method for treating patient who has undergone complete resection of mucosal melanoma. Pr... |
|
|
Invention
|
Use of anti-pd-1 antibody in combination with first-line chemotherapy in treatment of advanced no... |
|
|
Invention
|
Method of treating urothelial carcinoma.
The present invention discloses a method of treating a ... |
|
|
Invention
|
Anti-cd112r antibody and use thereof.
An antibody specifically binding to CD112R or an antigen b... |
|
|
Invention
|
Anti-tigit antibody pharmaceutical composition and application thereof.
A stable anti-TIGIT anti... |
|
2021
|
Invention
|
Use of an anti-pd-1 antibody and a cytotoxic anticancer drug in treatment of non-small cell lung ... |
|
|
Invention
|
Use of anti-pd-1 antibody in treatment of nasopharyngeal carcinoma.
The present invention relate... |
|
|
G/S
|
medicines for human purposes for the treatment of cancer, tumor, viral infection, gastrointestina... |
|
|
Invention
|
Anti-ctla-4 antibody and use thereof.
An antibody specifically binding to CTLA-4 or an antigen-b... |
|
|
G/S
|
Medicines for human purposes; medicated candies;
depuratives; medicines for veterinary purposes;... |
|
|
Invention
|
Anti-cldn-18.2 antibody and use thereof.
Provided are a CLDN-18.2 specific binding antibody or a... |
|
|
Invention
|
Pharmaceutical composition of anti-il-17a antibodies and use thereof.
Provided are a stable phar... |
|
|
Invention
|
Stable heavy isotopes in amide functional groups and uses thereof. There are provided isotope-enr... |
|
|
Invention
|
Use of anti-pd-1 antibody in treating neuroendocrine tumors.
The present disclosure relates to u... |
|
|
Invention
|
Use of anti-pd-1 antibody in treatment of tumors.
The present disclosure relates to use of an an... |
|
|
Invention
|
Use of anti-pd-1 antibody in treatment of malignancy.
The present disclosure relates to use of a... |
|
2020
|
G/S
|
medicines for human purposes; Medicated candy; depuratives; medicines for veterinary purposes; Fu... |
|
|
G/S
|
medicines for human purposes for the treatment of gastrointestinal diseases, the treatment of car... |
|
|
Invention
|
Improved uricase and method for treating hyperuricemia using same.
Provided are an improved uric... |
|
|
G/S
|
Medicines for human purposes; medicated sweets; depuratives;
medicines for veterinary purposes; ... |
|
|
G/S
|
Medicines for human purposes, namely, medicinal preparations for headaches; medicated sweets; dep... |
|
|
Invention
|
Anti-tigit antibodies and application thereof.
Provided are antibodies that bind specifically to... |
|
2019
|
Invention
|
Anti-il-17a antibody and use thereof. The present invention provides an antibody or a functional ... |
